Ra Pharmaceuticals to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 28, 2019--
Ra Pharmaceuticals, Inc. (Nasdaq: RARX) today announced that senior management will present at the following upcoming investor conferences:
- The Jefferies 2019 Healthcare Conference on Tuesday, June 4, 2019, at 2:30 p.m. E.T.
- The Raymond James Life Sciences and MedTech Conference on Wednesday, June 19, 2019, at 10:20 a.m. E.T. The conference will be held at the Lotte New York Palace in New York, NY.
- The BMO 2019 Prescription for Success Healthcare Conference on Tuesday, June 25, 2019, at 8:00 a.m. E.T. The conference will be held at the Mandarin Oriental New York in New York, NY.
The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of each presentation will be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190528005175/en/
Natalie Wildenradt, 617-674-9874
David Rosen, 212-600-1902
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL RESEARCH SCIENCE MANAGED CARE
SOURCE: Ra Pharmaceuticals, Inc.
Copyright Business Wire 2019.
PUB: 05/28/2019 07:00 AM/DISC: 05/28/2019 08:05 AM